Last reviewed · How we verify

NCT05997355

Preoperative Gabapentin for Cosmetic Breast Surgery

Status unknown NA Last updated 18 August 2023
What this trial tests

NA trial testing Gabapentin 600Mg Tab in Postoperative Pain in 100 participants. Status unknown.

Timeline
1 September 2023
Primary endpoint
31 July 2024
31 July 2024

Quick facts

Lead sponsorUniversity of Puerto Rico
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment100
Start date1 September 2023
Primary completion31 July 2024
Estimated completion31 July 2024

Drugs / interventions tested

Conditions studied

Sponsor

University of Puerto Rico

Who can join

Adults 18 to 65, any sex, with Postoperative Pain or Opioid Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare postoperative pain and opioid consumption in patients who undergo cosmetic breast surgery and are treated preoperatively with gabapentin. The main questions to answer are the amount of postoperative pain on a scale of 0-10 and amount of opioids consumed postoperatively. Participants will be randomized into two groups: treatment vs no treatment. Treatment group will receive 600mg of gabapentin preopreatively. Researchers will compare treatment vs no treatment group to determine the effects of preoperative gabapentin on postoperative pain management and opioid consumption.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other University of Puerto Rico trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05997355.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing